Gualberto Ruaño
Gualberto Ruaño is a pioneer in the field of personalized medicine and the inventor of molecular diagnostic systems used worldwide for the management of viral diseases. Ruaño is President and Founder of Genomas, a genetics-related company and now the bio-tech anchor of Hartford Hospital’s Genetic Research Center; he also serves as Director of genetics research at the Center. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Gualberto Ruaño', query time: 0.03s
Refine Results
-
1
-
2
A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics. by Jorge Duconge, Alga S Ramos, Karla Claudio-Campos, Giselle Rivera-Miranda, Luis Bermúdez-Bosch, Jessicca Y Renta, Carmen L Cadilla, Iadelisse Cruz, Juan F Feliu, Cunegundo Vergara, Gualberto Ruaño
Published 2016-01-01
Article -
3
Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study by Karla Claudio-Campos, Aurora Labastida, Alga Ramos, Andrea Gaedigk, Jessicca Renta-Torres, Dariana Padilla, Giselle Rivera-Miranda, Stuart A. Scott, Stuart A. Scott, Gualberto Ruaño, Carmen L. Cadilla, Jorge Duconge-Soler
Published 2017-06-01
Article -
4
Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach by Jorge Duconge, Ednalise Santiago, Dagmar F. Hernandez‐Suarez, Mariangeli Moneró, Andrés López‐Reyes, Marines Rosario, Jessicca Y. Renta, Pablo González, Laura Ileana Fernández‐Morales, Luis Antonio Vélez‐Figueroa, Orlando Arce, Frances Marín‐Maldonado, Héctor Nuñez, Kyle Melin, Stuart A. Scott, Gualberto Ruaño
Published 2021-11-01
Article